The serum IgG antibody level as a biomarker for clinical outcome in patients with cerebral sparganosis after treatment

This study provided evidence that the serum IgG antibody level of sparganum was a promising biomarker to evaluate the prognosis of patients with cerebral sparganosis after treatment.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research